0
2021
Cancer Immunotherapy Market

Cancer Immunotherapy Market

by Technology Type (Monoclonal Antibodies, Cytokines & Immunomodulators, and Others), Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, and Others), and End user (Hospitals, Cancer Research Centers, and Clinics): Global Opportunity Analysis and Industry Forecast, 2021-2030
Update Available On-Demand

Report Code: A01913
Pages: 207
Jul 2021 | 21273 Views
Author(s) : Kishor Sherkar, Stephy Varghese , Onkar Sumant
Tables: 113
Charts: 53
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Cancer Immunotherapy Market

Request Now !

Cancer Immunotherapy Market Overview 2030:

The global cancer immunotherapy market size was valued at $85,603.50 million in 2020, and is projected to reach $309,667.65 million by 2030, registering a CAGR of 14.1% from 2021 to 2030.

The COVID-19 pandemic has drastically affected buying capacity of hospitals, especially small-scale hospitals and scanning centers. According to an article by Cigna, there has been reductions in hospitalizations for non-elective conditions such as acute coronary syndromes and transient ischemic attacks that raise the possibility that patients may be deferring necessary elements of clinical care. The clinical trials of the new cancer immunotherapy drugs are kept on hold, as during this crisis the individual is more susceptible to suffer from COVID-19. COVID friendly cancer treatment however, are observed to be increased during the course of time and would propel in the coming years. Thus, the COVID-19 pandemic is anticipated to have a negative impact on the cancer immunotherapy market.

Cancer immunotherapy is a cancer treatment that enhances the immune system's ability to fight cancer. This therapy is preferable than the old technique because it provides long-term cancer protection, has less side effects, and treats a wider range of cancer. Cancer immunotherapy is used in different types of cancers such as melanoma, prostate cancer, breast cancer, colorectal cancer, lung cancer, head & neck cancer, and more. Immunotherapy works by directing the immune system toward cancer-specific targets, activating the immune system to mobilize the target, and triggering a response capable of destroying cancer cells. 

Cancer-Immunotherapy-Market-2021-2030

There are many factors, such as increase in healthcare expenditure, rise in incidence of cancer, surge in access to medical insurance, and surge in technological advancements in cancer treatment therapies expected to propel the growth of the global cancer immunotherapy market. According to statistics given by national cancer institute in 2020, an estimated 1,806,590 new cases of cancer were diagnosed in the U.S. and 606,520 people passed away due to the disease. This surge in the incidences of cancer propel the growth of the industry in the coming years. Increase in awareness programs regarding the need for cancer immunotherapy is expected to help the market gain traction during the forecast period. However, the factors such as stringent regulations related to cancer immunotherapy are anticipated to hinder the growth of the cancer immunotherapy market. Government have better supervision over the use of immunotherapy and is also taking care of the clinical trials going on user the government norms, which has made it difficult to the companies to enter the industry and is hence expected to hinder the growth of the market. Also, high product developmental cost is anticipated to impede the growth of the cancer immunotherapy market.

Global Cancer Immunotherapy Market Segmentation

The cancer immunotherapy market is categorized into technology type, application, end-user, and region. By technology type, the market is divided into monoclonal antibodies, cytokines & immunomodulators, and others. Monoclonal antibodies held the largest share in 2020, owing to surge in usage of monoclonal antibodies for cancer immunotherapy as they exhibit different properties where immune system can be modulated and hence they can activate or inhibit the molecules targeted on immune system. In addition, monoclonal antibodies also induce the antitumor immune response.

Cancer Immunotherapy Market
By Product

Your browser does not support the canvas element.

The monoclonal antibodies segment is expected to lead the market throughout the forecast period.

Get more information on this report : Request Sample Pages

By application, the cancer immunotherapy market is segmented as lung cancer, breast cancer, colorectal cancer, melanoma, prostate cancer, head & neck cancer, and other applications. The lung cancer market held the largest share in 2020 and is expected to lead the market during the analysis period owing to high incidence of lung cancer worldwide and surge in the awareness program regarding the need for early therapeutics of lung cancer.

Cancer Immunotherapy Market
By Application

Your browser does not support the canvas element.

The lung cancer segment is expected to lead the market throughout the forecast period.

Get more information on this report : Request Sample Pages

On the basis of end user, the market is categorized into hospitals, cancer research centers and clinics. Hospitals held the largest market share of cancer immunotherapy market in 2020, and this segment is projected to show the highest growth rate during the analysis period due to the extensive use of cancer immunotherapy in the hospitals. Furthermore, higher preference toward hospitals is anticipated to boost the growth of the segment during the forecast period. Furthermore, hospitals segment would gain highest CAGR of about 14.7% in the forecast period. 

Cancer Immunotherapy Market
By End User

Your browser does not support the canvas element.

The hospitals segment spearheaded the market in 2020 and is expected to maintain the dominance throughout the forecast period.

Get more information on this report : Request Sample Pages

Region wise, the cancer immunotherapy market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America was the highest revenue contributor in 2020. This is attributed to the steep rise in amount of expenditure in healthcare, increased focus on maintaining best healthcare system, and increased incidence of cancer worldwide. However, Asia-Pacific is projected to grow with the highest CAGR during the analysis period, owing to rise in healthcare expenditure, surge in per capita income, and improvement in healthcare infrastructure. In addition, Europe is expected to gain second largest revenue share during the forecast period, owing to the development in the infrastructure in the region and rising incidences of cancer.

Cancer Immunotherapy Market
By Region

2030
North America 
Europe
Asia-pacific
Lamea

North America held a highest revenue share in 2020, whereas, Europe will be the second-largest value contributor, and Asia-Pacififc is expected to register the fastest CAGR during the forecast period.

Get more information on this report : Request Sample Pages

The key players operating in the global cancer immunotherapy market include Amgen, Inc., Astrazeneca, PLC, Bayer AG, Bristol-Myers Squibb Company, Eli Lily And Company, F. Hoffmann-La Roche, Ltd. (Genentech, Inc.), Pfizer, Inc., Johnson & Johnson (Janssen Global Services, LLC), Merck KGAA, and Novartis AG.

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the global cancer immunotherapy market size along with the current trends and future estimations to elucidate the imminent investment pockets
  • It offers market analysis from 2021 to 2030, which is expected to enable stakeholders to capitalize on the prevailing opportunities in the cancer immunotherapy market
  • A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global cancer immunotherapy market growth

Key Market Segments

By Technology Type

  • Monoclonal Antibodies
  • Cytokines & Immunomodulators
  • Others

By Application

  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Melanoma
  • Prostate Cancer
  • Head & Neck Cancer
  • Others

By End user

  • Hospitals
  • Cancer Research Centers
  • Clinics

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East
    • Africa

List of key players profiled in the report

  • Amgen, Inc.
  • Astrazeneca, PLC
  • Bayer AG
  • Bristol-Myers Squibb Company
  • Eli Lily And Company
  • F. Hoffmann-La Roche, Ltd. (Genentech, Inc.)
  • Pfizer, Inc. 
  • Johnson & Johnson (Janssen Global Services, LLC)
  • Merck KGAA
  • Novartis AG
 

Loading Table Of Content...


 
 

Cancer immunotherapy, is commonly referred to as biologic therapy, helps in boosting the immunity of body to fight against cancer. In this type of therapy, antibodies and live viruses are introduced in the body that delay the growth of the cancer cells. 

Surge in incidence of cancer globally, increase in healthcare expenditure, and rise in geriatric population who are susceptible to suffer from cancer are anticipated to propel the growth of the global cancer immunotherapy market. Surge in awareness programs regarding the need for cancer immunotherapy is expected to help the market gain traction during the forecast period. Rise in the incidences of cancer is anticipated to propel the growth of the industry during the forecast period. However, factor such as stringent regulations related to cancer immunotherapy is expected to inhibit the growth of the cancer immunotherapy market. 

North America is expected to remain dominant during the forecast period, owing to increase in demand for cancer immunotherapy, rise in incidences of chronic orthopedic conditions, and presence of major key players along with R&D centers. Moreover, Asia-Pacific and LAMEA are expected to offer significant opportunities to key players during the forecast period, owing to increase in number of hospitals equipped with advanced medical facilities along with increase in utilization of cancer immunotherapy.
 

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. Cancer immunotherapy is a method of cancer treatment that helps in boosting immune system in fighting cancer.

A. Cancer immunotherapy is used for the treatment of cancer with the help of various technologies such as monoclonal antibodies and others and hence in destruction of the tumor cells from the body using immune system response.

A. The total value of cancer immunotherapy market was $85,603.5 million in 2020.

A. The forecast period in the report is from 2021-2030.

A. The market value of opthalmic devices market in 2030 was $3,09,667.5 million.

A. The base year calculated in the report is 2020.

A. Increased demand for the cancer immunotherapy and rise in incidences of cancer will drive the market over the near future according to the KOLs.

A. The market has drawn the interest of the healthcare industry, owing to increasing prevalence of cancer diseases, rise in technological advancements in cancer immunotherapy, and growing awareness among consumers regarding cancer immunotherapy

A. By technology type, themonoclonal antibodies segment holds the maximum market share.

A. The market in Asia-Pacific is expected to register lucrative CAGR of 11.00% over the forecast period owing to presence of large population base, increase in awareness regarding cancer immunotherapy, and rise in disposable income

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Free Sample

OR

Purchase Full Report of
Cancer Immunotherapy Market

Start reading instantly.
This Report and over 18,758+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Jul 2022 - Jul 2023)
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jul 2022 - Jul 2023)
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jul 2022 - Jul 2023)
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jul 2022 - Jul 2023)
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jul 2022 - Jul 2023)
  • Library
    Membership

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers